Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Loeffler

Showing results (211-220 of 329) with videos related to

Pageof 33
Sort By:
Blood|May 30, 2008
Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trialsWolfram Klapper, Monika Szczepanowski, Birgit Burkhardt, et al.
Biology of Sex Differences|March 27, 2024
Sex and statin-related genetic associations at the PCSK9 gene locus: results of genome-wide association meta-analysisJanne Pott, Azin Kheirkhah, Jesper R Gadin, et al.
International Journal of Cancer|April 26, 2005
Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancerElisabeth Mangold, Constanze Pagenstecher, Waltraut Friedl, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 20, 2009
Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancerChristoph Engel, Nils Rahner, Karsten Schulmann, et al.
BMC Medical Informatics and Decision Making|June 16, 2026
A distributed analysis approach for pharmacovigilance data from electronic medical records in German university hospitals: the POLAR_MI ETL PipelineMiriam Kesselmeier, Torsten Thalheim, Florian Schmidt, et al.
International Journal of Cancer|July 9, 2005
Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancerChristoph Engel, Jochen Forberg, Elke Holinski-Feder, et al.
The Lancet. Haematology|March 5, 2021
Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trialFabian Frontzek, Marita Ziepert, Maike Nickelsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2007
Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trialAndreas Engert, Jeremy Franklin, Hans Theodor Eich, et al.
International Journal of Cancer|June 15, 2017
TP53 mutation and survival in aggressive B cell lymphomaThorsten Zenz, Markus Kreuz, Maxi Fuge, et al.
Blood|January 22, 2013
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphomaHeike Horn, Marita Ziepert, Claudia Becher, et al.
Pageof 33

Showing results (211-220 of 329) with videos related to

Sort By:
Pageof 33
Blood|May 30, 2008
Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trialsWolfram Klapper, Monika Szczepanowski, Birgit Burkhardt, et al.
Biology of Sex Differences|March 27, 2024
Sex and statin-related genetic associations at the PCSK9 gene locus: results of genome-wide association meta-analysisJanne Pott, Azin Kheirkhah, Jesper R Gadin, et al.
International Journal of Cancer|April 26, 2005
Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancerElisabeth Mangold, Constanze Pagenstecher, Waltraut Friedl, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 20, 2009
Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancerChristoph Engel, Nils Rahner, Karsten Schulmann, et al.
BMC Medical Informatics and Decision Making|June 16, 2026
A distributed analysis approach for pharmacovigilance data from electronic medical records in German university hospitals: the POLAR_MI ETL PipelineMiriam Kesselmeier, Torsten Thalheim, Florian Schmidt, et al.
International Journal of Cancer|July 9, 2005
Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancerChristoph Engel, Jochen Forberg, Elke Holinski-Feder, et al.
The Lancet. Haematology|March 5, 2021
Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trialFabian Frontzek, Marita Ziepert, Maike Nickelsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2007
Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trialAndreas Engert, Jeremy Franklin, Hans Theodor Eich, et al.
International Journal of Cancer|June 15, 2017
TP53 mutation and survival in aggressive B cell lymphomaThorsten Zenz, Markus Kreuz, Maxi Fuge, et al.
Blood|January 22, 2013
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphomaHeike Horn, Marita Ziepert, Claudia Becher, et al.
Pageof 33